No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong Anders Heijl?

Dr. Anders Heijl

Senior Professor

Lund University

Direct Phone: +46 ** ** ** **       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Lund University

Paradisgatan 2

Lund, Skane 22100


Company Description

Lund is an historical town situated in the southernmost part of Sweden ( Lund University was founded in 1666 ( and its campus reflects the University's history, with magnificent buildings separated by cobbled streets ... more

Find other employees at this company (6,078)

Background Information

Employment History

Chairman, Department of Ophthalmology


Study Director of the Early Manifest Glaucoma Trial, An Inventor



Carl Zeiss Meditec AG


Chairman Lund University Dept of Ophthalmology Malmö University Hospital Malmö


Honorary Member
Glaucoma Research Society



Web References (35 Total References)

Glaucoma 2004 - Invited Speakers [cached]

Anders Heijl, MDProfessor of OphthalmologyDepartment of OphthalmologyLund University

Glaucoma 2008 - Invited Speakers [cached]

Anders Heijl, MDProfessor of OphthalmologyDepartment of OphthalmologyLund University

Dr. Anders Heijl Past ... [cached]

Dr. Anders Heijl Past president

Members [cached]

Dr. Anders Heijl, Sweden

Sight & Hearing Association [cached]

These results should be put into perspective, according to Anders Heijl, M.D., Ph.D., chairman of the Department of Ophthalmology at Sweden's Malmö University Hospital and first author of the report. "Although the study closely checked for possible glaucoma progression, many of the patients remained stable over time, even those in the control group," Dr. Heijl said. "On the other hand, despite the clear effect of treatment, glaucoma progressed in as many as 30 percent of treated patients after four years."

Dr. Heijl said that the time it took for glaucoma to progress varied greatly among patients and was sometimes rather short, even in treated patients. "This shows that in many patients with rapidly progressing glaucoma, the treatment used in this study was insufficient to halt progression of the disease," Dr. Heijl said.
Dr. Heijl emphasized that treatment for early, newly diagnosed glaucoma should be individualized and carefully balanced. Before deciding on the best treatment option, eye care professionals should consider several unique patient factors, such as age, eye pressure levels, and disease severity. "The study findings support the medical community's growing contention that glaucoma treatment should be tailored to the individual needs of the patient," Dr. Heijl said.

Similar Profiles

Other People with this Name

Other people with the name Heijl

Marko Heijl
Soudal N.V

David Heijl
Esko NV

Robert van Heijl

Marko Heijl
Karel de Grote-Hogeschool

Astrid van Heijl
Debenhams plc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory